1. Home
  2. FLYX vs GOSS Comparison

FLYX vs GOSS Comparison

Compare FLYX & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo flyExclusive Inc.

FLYX

flyExclusive Inc.

N/A

Current Price

$1.21

Market Cap

63.1M

Sector

Finance

ML Signal

N/A

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$10.36

Market Cap

70.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLYX
GOSS
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
70.8M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
FLYX
GOSS
Price
$1.21
$10.36
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $95.40
AVG Volume (30 Days)
159.8K
★ 221.8K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.61
N/A
EPS
N/A
★ N/A
Revenue
★ $375,877,000.00
$48,471,000.00
Revenue This Year
$8.30
N/A
Revenue Next Year
$15.15
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 14.85
N/A
52 Week Low
$1.05
$0.11
52 Week High
$8.88
$12.52

Technical Indicators

Market Signals
Indicator
FLYX
GOSS
Relative Strength Index (RSI) 50.66 58.71
Support Level $1.09 $0.18
Resistance Level $1.38 $12.49
Average True Range (ATR) 0.06 0.79
MACD 0.01 -0.07
Stochastic Oscillator 53.85 71.68

Price Performance

Historical Comparison
FLYX
GOSS

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet, which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: